4//SEC Filing
Abate Thomas M 4
Accession 0001225208-13-010469
CIK 0001099800other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 7:34 PM ET
Size
10.9 KB
Accession
0001225208-13-010469
Insider Transaction Report
Form 4
Abate Thomas M
CVP, CFO and Treasurer
Transactions
- Sale
Common Stock
2013-04-26$64.41/sh−8,800$566,808→ 46,688.976 total - Sale
Common Stock
2013-04-26$65.36/sh−1,200$78,432→ 55,488.976 total - Exercise/Conversion
Common Stock
2013-04-26$21.95/sh+10,000$219,550→ 56,688.976 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2013-04-26−10,000→ 15,000 totalExercise: $21.95From: 2007-05-11Exp: 2013-05-10→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2012.
- [F2]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $65.14 to $65.53. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $64.05 to $64.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001346974
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 7:34 PM ET
- Size
- 10.9 KB